Strategic Services for European Pharmaceutical Market Entry
NCB Consulting specializes in European pharma market entry and launch excellence with particular depth in DACH and France. Strategic market insights and commercial intelligence that drive launch decisions.
PATIENT JOURNEY STRATEGIC REDESIGN
Cultural and systemic mapping of how patients navigate diagnosis, treatment, and adherence across DACH/EU4 markets incorporating DEI factors often missed in generic archetypes.
Proprietary Cultural Patient Journey Methodology identifies underserved patient segments, cultural barriers, emotional friction, and systemic constraints.
Ideal For: Pre-launch planning, market entry strategy, patient segmentation refinement, post-launch optimization
-
Strategic patient journey analysis with DEI integration
Social listening (patient + HCP sentiment)
Secondary research and competitive positioning gaps
Cultural nuances and healthcare system differences across markets
Commercial opportunity assessment
Strategic recommendations with business case
Executive presentation + strategic memo
-
Single Market (DACH or one of EU4) | Multi-Market (EU4) | Global (EU + US)
-
6-14 weeks depending on geographic scope
COMPETITIVE INTELLIGENCE & CI ALERTS
Ongoing CI reports and real-time alerts covering competitor positioning, commercial moves, pricing announcements, and strategic signals across therapeutic areas.
Track 3-5 competitors across clinical pipelines, commercial messaging, and HCP engagement strategies. AI-powered synthesis for rapid analysis.
-
Competitor deep dives (3-5 competitors)
Clinical, commercial, and HCP engagement strategies
Social media competitive monitoring
Real-time CI alerts for critical competitive movements
Strategic vulnerabilities and response framework
Executive presentation + strategic memo
-
Ongoing weekly CI alerts
Congress coverage and intelligence gathering
Real-time competitor digital monitoring
-
4-10 weeks for initial analysis, ongoing alerts available
LAUNCH EXCELLENCE STRATEGY
Note: Provides strategic intelligence does NOT execute market access submissions, pricing dossiers, or reimbursement processes.
End-to-end commercial launch strategy from pre-launch positioning to go-to-market execution.
Comprehensive approach combining competitive intelligence, patient insights, and cross-functional commercial activation planning.
-
Launch readiness audit + competitive intelligence
Strategic segmentation + commercial positioning
12-month commercial activation plan with KPIs
Launch operating model + governance framework
Social media listening throughout launch period
Strategic playbook
-
10-20 weeks depending on geographic scope
MARKET POSITIONING STRATEGY
Clarity on where to play, how to win, and how to differentiate for products entering crowded or complex European markets. Strategic positioning frameworks grounded in how European commercial teams and healthcare systems actually operate.
Ideal For: Pre-launch planning, market entry strategy, patient segmentation refinement, post-launch optimization
-
Market landscape analysis
Strategic positioning framework and value proposition
Priority market identification and sequencing
Competitive advantage mapping
Go-to-market recommendations by market
-
Single Market (DACH or one of EU4) | Multi-Market (EU4) | Global (EU + US)
-
6-14 weeks depending on geographic scope
SOCIAL MEDIA LISTENING
Real-time patient, HCP, and competitive sentiment tracking with strategic recommendations for pharmaceutical brand positioning. Not just monitoring, strategic interpretation of what conversations mean for your commercial strategy.
-
Brand sentiment tracking across patient communities
HCP conversation analysis
Patient community insights and unmet needs
Competitor social monitoring
Crisis detection alerts
Strategic recommendations for brand engagement
Available As:
Project-based (3-6 months) | Monthly retainer | Integrated with other services
CONGRESS COVERAGE
On-site attendance at major pharmaceutical and medical conferences to gather competitive intelligence, track scientific developments, identify emerging commercial trends.
-
Competitor booth presence and commercial messaging
Scientific presentation monitoring
HCP informal conversations and sentiment
Emerging competitive threats
Post-congress strategic briefing with commercial implications
-
ASCO, ASH, ADA, EASD, ECTRIMS, EHA, ESC, and therapeutic area-specific conferences
AI-POWERED INTELLIGENCE
Rapid competitive reports and market analysis delivered 40% faster than traditional agencies, without sacrificing strategic depth. AI synthesis of competitive intelligence, market trends, and commercial signals for faster decision-making.
Ideal For: Pre-launch planning, market entry strategy, patient segmentation refinement, post-launch optimization
-
Rapid competitive reports and market analysis delivered 40% faster than traditional agencies without sacrificing strategic depth. AI synthesis of competitive intelligence, market trends, and commercial signals for faster decision-making.
-
2-7 days for rapid intelligence, ongoing monitoring available
OUR FOCUS AND EXPERTISE
What NCB Consulting DOES:
Commercial strategy and market insights
Patient journey intelligence and competitive positioning
Launch strategy development and commercial planning
Market opportunity assessment and competitive analysis
HCP engagement strategy and brand positioning
What NCB Consulting DOES NOT DO:
Pricing strategy execution or reimbursement submissions
Payer negotiations or HTA dossier preparation
Traditional market research (surveys, focus groups)
Clinical trial design or regulatory affairs
Sales force execution or medical affairs support